drugset / Trial / NCT00681733
Pentoxifylline Versus Pioglitazone In Non-Alcoholic Steatohepatiti (NASH)
RandomizedParallel-groupDouble-blindTreatment
Summary
1. To assess the metabolic factors in lean and obese patients with NASH. 2. To compare the efficacy of pentoxifylline versus pioglitazone on the metabolic profile and liver histology of NASH patients.
Timeline
- Start
- 2007-01
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pentoxifylline | Small molecule | 1200 mg | — |
| Subject | Pioglitazone | Small molecule | 30 mg | — |
Indications
No indication recorded.